Exencial Wealth Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $735K | Sell |
8,480
-130,901
| -94% | -$12.5M | 0.02% | 335 |
|
|
2025
Q4 | $13.4M | Sell |
139,381
-3,686
| -3% | -$358K | 0.42% | 65 |
|
|
2025
Q3 | $13.6M | Sell |
143,067
-69
| -0% | -$6.34K | 0.44% | 63 |
|
|
2025
Q2 | $12.5M | Sell |
143,136
-6,452
| -4% | -$547K | 0.44% | 67 |
|
|
2025
Q1 | $13.4M | Buy |
149,588
+730
| +0.5% | +$65.3K | 0.5% | 61 |
|
|
2024
Q4 | $11.9M | Sell |
148,858
-27,569
| -16% | -$2.39M | 0.44% | 63 |
|
|
2024
Q3 | $15.9M | Sell |
176,427
-5,631
| -3% | -$474K | 0.57% | 56 |
|
|
2024
Q2 | $14.3M | Sell |
182,058
-13,229
| -7% | -$1.08M | 0.54% | 60 |
|
|
2024
Q1 | $17M | Sell |
195,287
-937
| -0.5% | -$80K | 0.64% | 46 |
|
|
2023
Q4 | $16.2M | Buy |
196,224
+4,684
| +2% | +$357K | 0.66% | 47 |
|
|
2023
Q3 | $15M | Buy |
191,540
+253
| +0.1% | +$21.2K | 0.73% | 45 |
|
|
2023
Q2 | $16.9M | Buy |
191,287
+4,265
| +2% | +$367K | 0.77% | 36 |
|
|
2023
Q1 | $15.1M | Buy |
187,022
+5,535
| +3% | +$451K | 0.78% | 39 |
|
|
2022
Q4 | $14.1M | Buy |
181,487
+177,506
| +4,459% | +$14.4M | 0.76% | 41 |
|
|
2022
Q3 | $321K | Buy |
3,981
+289
| +8% | +$26K | 0.02% | 332 |
|
|
2022
Q2 | $331K | Buy |
3,692
+188
| +5% | +$19K | 0.02% | 333 |
|
|
2022
Q1 | $389K | Sell |
3,504
-4,223
| -55% | -$446K | 0.02% | 317 |
|
|
2021
Q4 | $799K | Buy |
7,727
+5,448
| +239% | +$631K | 0.04% | 248 |
|
|
2021
Q3 | $286K | Sell |
2,279
-4,850
| -68% | -$628K | 0.01% | 286 |
|
|
2021
Q2 | $885K | Buy |
7,129
+1,269
| +22% | +$159K | 0.05% | 248 |
|
|
2021
Q1 | $692K | Buy |
5,860
+613
| +12% | +$71.8K | 0.04% | 246 |
|
|
2020
Q4 | $615K | Sell |
5,247
-2,192
| -29% | -$241K | 0.04% | 227 |
|
|
2020
Q3 | $774K | Buy |
7,439
+2,262
| +44% | +$227K | 0.04% | 218 |
|
|
2020
Q2 | $475K | Sell |
5,177
-328
| -6% | -$31.5K | 0.04% | 223 |
|
|
2020
Q1 | $496K | Sell |
5,505
-84
| -2% | -$8.94K | 0.09% | 152 |
|
|
2019
Q4 | $634K | Sell |
5,589
-448
| -7% | -$49.2K | 0.11% | 151 |
|
|
2019
Q3 | $656K | Sell |
6,037
-650
| -10% | -$67.8K | 0.14% | 131 |
|
|
2019
Q2 | $651K | Hold |
6,687
| – | – | 0.15% | 125 |
|
|
2019
Q1 | $609K | Sell |
6,687
-315
| -4% | -$28.2K | 0.14% | 127 |
|
|
2018
Q4 | $637K | Buy |
7,002
+1,590
| +29% | +$149K | 0.17% | 116 |
|
|
2018
Q3 | $532K | Sell |
5,412
-298
| -5% | -$27.6K | 0.12% | 119 |
|
|
2018
Q2 | $489K | Buy |
5,710
+124
| +2% | +$10.4K | 0.14% | 114 |
|
|
2018
Q1 | $448K | Buy |
5,586
+1,759
| +46% | +$145K | 0.13% | 121 |
|
|
2017
Q4 | $309K | Sell |
3,827
-94
| -2% | -$7.53K | 0.09% | 143 |
|
|
2017
Q3 | $305K | Sell |
3,921
-165
| -4% | -$13.7K | 0.1% | 137 |
|
|
2017
Q2 | $363K | Buy |
4,086
+724
| +22% | +$61K | 0.15% | 107 |
|
|
2017
Q1 | $270K | Buy |
+3,362
| New | +$263K | 0.12% | 120 |
|
Other funds holding MDT
Exencial Wealth Advisors's MDT Position: Q1 2026 in Review
Exencial Wealth Advisors reduced its Medtronic (MDT) stake by 94% in Q1 2026, selling an estimated $12.5M and leaving 8,480 shares worth $735K. The position accounts for 0.02% of the portfolio, ranked #335.
Exencial Wealth Advisors first reported a position in MDT in Q1 2017 and has held it in 37 quarters since. The position peaked at $17M in Q1 2024. 2,246 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Exencial Wealth Advisors held 8,480 shares of Medtronic worth $735K as of Q1 2026.
- Exencial Wealth Advisors sold 130,901 Medtronic shares in Q1 2026, an estimated $12.5M.
- Medtronic made up 0.02% of Exencial Wealth Advisors's portfolio in Q1 2026, its #335 holding.
- Exencial Wealth Advisors first reported a position in Medtronic in Q1 2017 and has held it in 37 quarters since.
- Exencial Wealth Advisors's Medtronic position peaked at $17M in Q1 2024.
- 2,246 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.